Lakefront Biotherapeutics (LKFT)
29.65
-0.35
(-1.17%)
USD |
NASDAQ |
Oct 08, 15:13
Lakefront Biotherapeutics Market Cap : 1.947B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 1.970B |
| October 06, 2026 | 1.925B |
| October 05, 2026 | 1.937B |
| October 02, 2026 | 1.928B |
| October 01, 2026 | 1.895B |
| September 30, 2026 | 1.947B |
| September 29, 2026 | 1.938B |
| September 28, 2026 | 1.959B |
| September 25, 2026 | 1.929B |
| September 24, 2026 | 1.993B |
| September 23, 2026 | 2.017B |
| September 22, 2026 | 1.982B |
| September 21, 2026 | 1.943B |
| September 18, 2026 | 1.874B |
| September 17, 2026 | 1.898B |
| September 16, 2026 | 1.807B |
| September 15, 2026 | 1.833B |
| September 14, 2026 | 1.754B |
| September 11, 2026 | 1.760B |
| September 10, 2026 | 1.760B |
| September 09, 2026 | 1.801B |
| September 08, 2026 | 1.814B |
| September 04, 2026 | 1.871B |
| September 03, 2026 | 1.905B |
| September 02, 2026 | 1.892B |
| Date | Value |
|---|---|
| September 01, 2026 | 1.874B |
| August 31, 2026 | 1.871B |
| August 28, 2026 | 1.896B |
| August 27, 2026 | 1.933B |
| August 26, 2026 | 1.915B |
| August 25, 2026 | 1.950B |
| August 24, 2026 | 1.907B |
| August 21, 2026 | 1.891B |
| August 20, 2026 | 1.856B |
| August 19, 2026 | 1.928B |
| August 18, 2026 | 1.838B |
| August 17, 2026 | 1.807B |
| August 14, 2026 | 1.807B |
| August 13, 2026 | 1.841B |
| August 12, 2026 | 1.834B |
| August 11, 2026 | 1.886B |
| August 10, 2026 | 1.773B |
| August 07, 2026 | 1.779B |
| August 06, 2026 | 1.722B |
| August 05, 2026 | 1.719B |
| August 04, 2026 | 1.743B |
| August 03, 2026 | 1.762B |
| July 31, 2026 | 1.793B |
| July 30, 2026 | 1.821B |
| July 29, 2026 | 1.827B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 182.66B |
| ACADIA Pharmaceuticals, Inc. | 3.386B |
| Alkermes Plc | 6.728B |
| Alnylam Pharmaceuticals, Inc. | 30.04B |
| Amarin Corp. Plc | 252.03M |
Market Cap Related Metrics
| PE Ratio | 2.818 |
| PS Ratio | 1.721 |
| Price to Book Value | 0.5217 |
| Price | 29.65 |
| Earnings Yield | 35.49% |
| Operating PE Ratio | 2.891 |
| Normalized PE Ratio | 2.220 |